Scientists reported the success of a hair loss drug test in the United States that was more effective than expected. It was found that almost half of the participants had their hair grow back to their full head within 6 months.
It’s a critical breakthrough in the treatment of baldness from alopecia areata, found at all ages, the team of test scientists from Concert Pharmaceuticals said. In England it is found in 15 out of every ten thousand people.
Alopecia areata is caused by an immune disorder that destroys the hair follicles, resulting in hair loss. Some people may have patchy hair loss. But the symptoms can be mild and the hair can grow back. But in some people with severe symptoms, it can lead to baldness.
1st of its kind
There is currently no drug that directly treats the disease, only one that stimulates hair regrowth. Concert Pharmaceuticals, the developer of the CTP-543, is continuing its third, final, pre-approval clinical trial. Registered by the US Food and Drug Administration (FDA).
The trial enrolled 706 participants, divided into three groups: the 8 mg twice daily group, the 12 mg twice daily group, and the last placebo group. The real pills had more hair growth than the placebo group.
The result was that the first group had 30 percent of hair growing back at 80 percent or more, and the second group had 42 percent where hair had grown back 80 percent or more, which was the perfect test. because there are both random Volunteer fraud (double-blind) and placebo controls
Dr. Brett King, a dermatologist at the School of Medicine Yale University said it was an important day for the advancement of hair loss treatments. He was very pleased that the drug performed better than expected in the final test.
Dr. King further said that hair loss treatment is something that modern medicine is in great demand. And the latest results indicate that CTP-543 could be a potential therapy.
“CTP-543 is powerful enough to be one of the best hair loss treatments available today. It is one of the most neglected diseases by people and doctors,” said Dr King.
Concert Pharmaceuticals Co. expressed hope that the FDA will soon be able to certify the drug as one of the first that can be used to treat hair loss directly in the United States
According to the British National Health Insurance Institute (NHS), alopecia is common and no danger of concern. It could be a temporary condition due to stress, weight loss, or iron deficiency. or it may be permanent
The drug is used to treat Alopecia areata is an immune disorder that is different from hereditary hair loss. or hereditary hair loss known as androgenetic alopecia (male pattern hair loss).
